CRL - Charles River Laboratories International, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.32B
Enterprise Value 13.28B
Trailing P/E 20.82
Forward P/E 19.49
PEG Ratio (5 yr expected) 1.90
Price/Sales (ttm)2.53
Price/Book (mrq)3.32
Enterprise Value/Revenue 3.25
Enterprise Value/EBITDA 12.85

Trading Information

Stock Price History

Beta (5Y Monthly) 1.34
52-Week Change 3-14.91%
S&P500 52-Week Change 34.08%
52 Week High 3262.00
52 Week Low 3181.22
50-Day Moving Average 3196.29
200-Day Moving Average 3213.52

Share Statistics

Avg Vol (3 month) 3564.09k
Avg Vol (10 day) 3480.34k
Shares Outstanding 551.18M
Implied Shares Outstanding 6N/A
Float 850.58M
% Held by Insiders 10.98%
% Held by Institutions 199.00%
Shares Short (May 14, 2023) 41.34M
Short Ratio (May 14, 2023) 42.22
Short % of Float (May 14, 2023) 43.00%
Short % of Shares Outstanding (May 14, 2023) 42.62%
Shares Short (prior month Apr 13, 2023) 41.38M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2022
Most Recent Quarter (mrq)Mar 31, 2023


Profit Margin 12.13%
Operating Margin (ttm)16.41%

Management Effectiveness

Return on Assets (ttm)5.68%
Return on Equity (ttm)17.21%

Income Statement

Revenue (ttm)4.09B
Revenue Per Share (ttm)80.34
Quarterly Revenue Growth (yoy)12.60%
Gross Profit (ttm)1.46B
EBITDA 977.24M
Net Income Avi to Common (ttm)496.34M
Diluted EPS (ttm)9.80
Quarterly Earnings Growth (yoy)10.90%

Balance Sheet

Total Cash (mrq)201.59M
Total Cash Per Share (mrq)3.94
Total Debt (mrq)3.17B
Total Debt/Equity (mrq)100.38
Current Ratio (mrq)1.48
Book Value Per Share (mrq)60.74

Cash Flow Statement

Operating Cash Flow (ttm)626.39M
Levered Free Cash Flow (ttm)258.57M